SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 34 of 94
Health
A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new study
By
Chris Kay
and
Bloomberg
December 21, 2021
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By
Christiaan Hetzner
December 20, 2021
Commentary
Bangladesh Prime Minister: We rise from COVID-19 by helping the neediest first
By
Sheikh Hasina
December 20, 2021
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By
Suzi Ring
,
Naomi Kresge
and
Bloomberg
December 20, 2021
Health
Booster shots are the best defense against Omicron. But a rush on extra jabs may make it harder to stop the rise of new variants
By
Grady McGregor
and
Sophie Mellor
December 20, 2021
Health
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By
Christiaan Hetzner
December 17, 2021
Health
Omicron’s hospitalization rates are lower than previous COVID variants—at least in the hotspot that is South Africa
By
Sophie Mellor
December 17, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Bernhard Warner
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
Fauci says not all COVID tests are detecting Omicron, adding even more confusion to the holiday season
By
Megan Leonhardt
December 16, 2021
International
A desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
By
Christiaan Hetzner
December 16, 2021
Commentary
Extreme events are forcing corporations to think like insurers
By
Scott G. Stephenson
December 16, 2021
Omicron leads France to impose ‘more drastic’ border controls on travelers from COVID-stricken Britain
By
James Regan
and
Bloomberg
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh
Economy
Congressional Budget Office says Trump's immigration crackdown will shrink U.S. population faster than expected, a...
By
Sasha Rogelberg